Berndt H
Hoppe Seylers Z Physiol Chem. 1979 Jun;360(6):747-60.
The synthesis of sequence 71-86 of human proinsulin (sequence 6-21 of human insulin A-chain) via its monomeric cyclic dicystine peptide derivative (XXII) and the corresponding tetra-S-trityl-peptide derivative (XVIII) is described. The good solubility of the derivatives (XXII, XVIII) in orgranic solvents makes it possible to purify both the derivatives in their protected form. The S-trityl derivative (XVIII) enables the synthesis of the fragment 71-86 in a scale needed for the planned synthesis of human proinsulin.
描述了通过人胰岛素原71-86序列(人胰岛素A链6-21序列)的单体环二胱氨酸肽衍生物(XXII)和相应的四-S-三苯甲基肽衍生物(XVIII)进行合成。衍生物(XXII、XVIII)在有机溶剂中的良好溶解性使得以其保护形式纯化这两种衍生物成为可能。S-三苯甲基衍生物(XVIII)能够按计划合成人胰岛素原所需的规模合成片段71-86。